Relevance of increased serum cystatin C to vascular alterations in obese children

Pediatric Obesity

Volumn 7, Issue 5, 2012, Pages 374-381

  Dubern, B ^a,b,c,d   Lafarge, J C ^a,b,c   Fellahi, S ^b,c,e   Naour, N ^a,b,c   Copin, N ^f,g   Bastard, J P ^b,c,e   Simon, C ^f,g   Clement K ^a,b,c,h,i   Bonnet, D ^j   Tounian, P ^a,b,c,d   Guerre Millo, M ^a,b,c  

^a Institute of Cardiometabolism and Nutrition   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e HÔPITAL TENON   (France)

^f UNIVERSITÉ LYON 1   (France)

^g UNIVERSITÉ DE STRASBOURG   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ Center of Research on Human Nutrition Ile de France   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

Children; Cystatin C; Obesity; Vascular alterations

Indexed keywords

ADIPONECTIN; CREATININE; CYSTATIN C; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTERIAL WALL THICKNESS; ARTERY DILATATION; ARTICLE; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMMON CAROTID ARTERY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

ADIPONECTIN; ADOLESCENT; BODY MASS INDEX; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CHILD; CYSTATIN C; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; TUNICA INTIMA; TUNICA MEDIA;

EID: 84867323980     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/j.2047-6310.2012.00053.x     Document Type: Article

References (36)

1. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004; 30: 13-19.
2. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
3. Naour N, Fellahi S, Renucci JF, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity (Silver Spring) 2009; 17: 2121-2126.
4. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR - history, indications, and future research. Clin Biochem 2005; 38: 1-8.
5. Bacchetta J, Cochat P, Rognant N, Ranchin B, Hadj-Aissa A, Dubourg L. Which creatinine and cystatin C equations can be reliably used in children? Clin J Am Soc Nephrol 2011; 6: 552-560.
6. Turk V, Stoka V, Turk D. Cystatins: biochemical and structural properties, and medical relevance. Front Biosci 2008; 13: 5406-5420.
7. Lecaille F, Bromme D, Lalmanach G. Biochemical properties and regulation of cathepsin K activity. Biochimie 2008; 90: 208-226.
8. Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-1197.
9. Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 2005; 96: 368-375.
10. Bengtsson E, To F, Hakansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25: 2151-2156.
11. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352: 2049-2060.
12. Luc G, Bard JM, Lesueur C, et al. Plasma cystatin-C and development of coronary heart disease: the PRIME Study. Atherosclerosis 2006; 185: 375-380.
13. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation 2007; 115: 173-179.
14. Retnakaran R, Connelly PW, Harris SB, Zinman B, Hanley AJ. Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. Pediatr Nephrol 2007; 22: 1007-1013.
15. Tounian P, Aggoun Y, Dubern B, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001; 358: 1400-1404.
16. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006; 55: 113-118.
17. Atabek ME, Pirgon O, Kivrak AS. Evidence for association between insulin resistance and premature carotid atherosclerosis in childhood obesity. Pediatr Res 2007; 61: 345-349.
18. Giannini C, de Giorgis T, Scarinci A, et al. Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis 2008; 197: 448-456.
19. Beauloye V, Zech F, Tran Thi Mong H, Clapuyt P, Maes M, Brichard SM. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 2007; 92: 3025-3032.
20. Baker JL, Olsen LW, Sorensen TI. Childhood bodymass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357: 2329-2337.
21. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991; 45: 13-21.
22. Simon C, Wagner A, DiVita C, et al. Intervention centred on adolescents' physical activity and sedentary behaviour (ICAPS): concept and 6-month results. Int J Obes Relat Metab Disord 2004; 28: S96-S103.
23. Aggoun Y, Bonnet D, Sidi D, et al. Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 2070-2075.
24. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
26. Ahmed ML, Ong KK, Dunger DB. Childhood obesity and the timing of puberty. Trends Endocrinol Metab 2009; 20: 237-242.
27. Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006; 55: 1840-1846.
28. Pena AS, Belobrajdic DP, Wiltshire E, Gent R, Hirte C, Couper J. Adiponectin relates to smooth muscle function and folate in obese children. Int J Pediatr Obes 2010; 5: 185-191.
29. Masaie H, Oritani K, Yokota T, et al. Adiponectin binds to chemokines via the globular head and modulates interactions between chemokines and heparan sulfates. Exp Hematol 2007; 35: 947-956.
30. Asanuma K, Shirato I, Ishidoh K, Kominami E, Tomino Y. Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. Kidney Int 2002; 62: 822-831.
31. Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int 2009; 76: 145-148.
32. Lane HA, Smith JC, Davies JS. Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag 2006; 2: 19-30.
33. Pilz S, Horejsi R, Moller R, et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J Clin Endocrinol Metab 2005; 90: 4792-4796.
34. Mathiesen EB, Johnsen SH, Wilsgaard T, Bonaa KH, Lochen ML, Njolstad I. Carotid plaque area and intimamedia thickness in prediction of first-ever ischemic stroke: a 10-year follow-up of 6584 men and women: the Tromso Study. Stroke 2011; 42: 972-978.
35. Weingartner O, Pinsdorf T, Rogacev KS, et al. The relationships of markers of cholesterol homeostasis with carotid intima-media thickness. PLoS ONE 2011; 5: e13467.
36. Lafarge JC, Naour N, Clement K, Guerre-Millo M. Cathepsins and cystatin C in atherosclerosis and obesity. Biochimie 2011; 92: 1580-1586.